Top Companies in the Microfluid Market | Leading Players Insightful Report by VMR
Microfluidics technologies provide quick analysis, reduced reagent consumption, and accurate test results, all of which contribute to lower overall drug development costs.
Coralia.Joe
Up Coming Trends in Microfluid Market
The Global Microfluidics Market is valued at USD 18.62 Billion in the year 2021 and is projected to reach a value of USD 45.15 Billion by the year 2028. The Global Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 15.90% over the forecast period. Microfluidic technology is an enabling platform technology that allows automation and multiplexing of laboratory equipment, drug screening technologies, and In-vitro diagnostic devices. With the growing completion of humans and the advent of next-generation sequencing, microfluidic technology has been used to increase automation and decrease turnaround times in genomics.
The major driver driving the microfluids market is the rising demand for point-of-care testing centers across the globe. Also increasing technological advancements in the field of microfluidics are fueling the growth of the market. For instance, according to World Health Organization (WHO), 95 million people received HIV testing in low and middle-income countries in 2010. The application of microfluidics in HIV testing at POCs is expected to cut costs, thereby increasing the demand for the technology.
Some of the key contributors in the field of microfluidics market are as below:
|
Company Name |
Revenue in USD |
|
$4 Billion |
|
$6 Billion |
|
$136 Million |
|
$1 Billion |
|
$6 Million |
|
$3 Billion |
|
$43 Billion |
|
$71 Billion |
|
$136 Million |
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is listed on NASDAQ as ILMN. In 2020, the company generated revenue of USD 32.3 billion and has 9,100 employees working. The company has numerous subsidiaries such as GRAIL, Illumina Korea Limited., Emedgene Inc., and various others. Illumina currently has a monopoly on the NGS space. The company has somehow managed to successfully eliminate most of its competition in the sequencing market.
Agilent Technologies, Inc. is an American analytical instrumentation development founded in 1999 and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The company is listed in New York Stocks market as A (NYSE). In 2020, the company generated revenue of USD 53.39 billion and has approximately 17,000 employees. The company has numerous subsidiaries such as Varian, Inc., BioTek, Resolution Bioscience, Inc., and various others. Agilent Technologies has developed a novel active real-time millimeter-wave imaging system for concealed weapon detection.
PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation focused on the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging, informatics, and service. The company operated in the “MedTech” domain and generates approximately USD 5 billion (2021). In 2021, the company had 16,000 employees working across the globe.
Cepheid is an American molecular diagnostics company. Its systems automate traditional nucleic acid tests. The tests can be used to identify and analyze pathogens and genetic disorders. Cepheid sells clinical tests for healthcare-associated infections, infectious diseases, sexual health, oncology, and genetics. The company was founded in 1996 and has 2,000 employees working across the U.S. the company has subsidiaries such as Cepheid AB, Stretton Scientific Limited, and many more. The parent organization of the company is Danaher Corporation.
Thermo Fisher Scientific is an American supplier of scientific instrumentation, reagents and consumables, and software services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. In 2021, the company generated revenue of USD 39.21 billion and had a net income of USD 7.72 billion. The company was founded in 1956 and has numerous subsidiaries such as PPD, Inc., Dionex, Patheon, Acros Organics B.V.B.A. The company offers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through industry-leading brands such as including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company is listed as BIO (NYSE) on New York Stock Market. The company is headquartered in Hercules, California, United States, and holds 8,250 employees. Bio-Rad Laboratories were founded in 1952. The company has various subsidiaries such as Bio-Rad France Holding, DiaMed Holding AG, and others. Bio-Rad Laboratories 2020 shares outstanding were 0.03B, a 0.08% decline from 2019. Bio-Rad Laboratories 2019 shares outstanding were 0.03B, a 0.15% decline from 2018.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company is listed in the New York stock market as ABT (NYSE). In 2020, the company generated revenue of USD 34.6 billion and has approximately 1,09,000 employees working across the globe. The company has numerous subsidiaries such as Alere Inc., Abbott India Ltd, Cardio MEMS, and many more. The company is headquartered in Chicago, Illinois, United States and since 2020, the CEO of the company is Robert Ford.
Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. The company is listed on the Swiss stock market as ROG (SWX). In 2020, the company generated revenue of USD 61.80 billion and holds approximately 1,01,200 employees. The company has various subsidiaries such as Genentech, Chugai Pharmaceutical Co., and many more.
Fluidigm Corporation is a public, American company engaged in the design, manufacture, and sale of biological research equipment based on integrated fluidic circuit technology. In 2009, Fluidigm was described as "the world's leading manufacturer of microfluidic devices. The company is listed as LAB on NASDAQ and generates revenue of USD 1.31 billion. The company is a privately held organization consisting of 500 employees.
Read Latest Blog Top Companies in the Prepacked Chromatography Columns Market: https://v-mr.biz/prepacked-chromatography-columns-market
Get a Free Sample Here: https://www.vantagemarketresearch.com/microfluidics-market-1485/request-sample
For More Information about each of these companies.
Vantage Market Research Report comes up with a detailed analysis of each major player in the industry. The Study provides Global market size & share, Emerging trends, an in-depth analysis of key players, Development opportunities, Sales, and a Revenue Forecast.
